1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with bromodeoxyuridine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lau, CB; Leung, PC; Wong, CK; Yang, H; Yue, GG; Zhang, YJ | 1 |
1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and bromodeoxyuridine
| Article | Year |
|---|---|
Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition.
Topics: Actin Depolymerizing Factors; Animals; Bromodeoxyuridine; Cathepsin B; Cell Line, Tumor; Colonic Neoplasms; Extracellular Matrix; Glucose; Humans; Hydrolyzable Tannins; Interleukin-10; Interleukin-2; Interleukin-6; Mice; Tumor Necrosis Factor-alpha | 2022 |